CFTR and cystic fibrosis: Therefore, patients should be informed to notify the CF healthcare providers if considering discontinuation of a CFTR modulator so that a plan to do so safely and with close monitoring can be established, and also to ensure refills are requested in advance to avoid lapses in therapy.